MedTrace Logo

Calcium Phosphate and Incretins

NCT01296997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-11-07

No results posted yet for this study

Summary

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Conditions

  • Healthy Men

Interventions

DIETARY_SUPPLEMENT

calcium phosphate

the subjects consumed for 3 weeks a bread enriched with 1 g pentacalcium phosphate per day

OTHER

placebo

the subjects consumed a bread without pentacalcium phosphate

Sponsors & Collaborators

  • University of Jena

    lead OTHER

Principal Investigators

  • Gerhard Jahreis, Prof. Dr. · Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01296997 on ClinicalTrials.gov